copd exacerbation - Nursing Case Study

Pathophysiology

• Primary mechanism: Airway inflammation - COPD exacerbations often stem from increased inflammation in the airways, typically triggered by infections or environmental pollutants. This inflammation leads to swelling and mucus production, narrowing airways and obstructing airflow.

• Secondary mechanism: Oxidative stress - An imbalance between oxidants and antioxidants exacerbates tissue damage in the lungs. Oxidative stress enhances inflammatory response, further impairing lung function and contributing to airway remodeling.

• Key complication: Gas exchange impairment - The inflammation and oxidative stress lead to ventilation-perfusion mismatch, reducing oxygen intake and carbon dioxide elimination, which can escalate to respiratory failure if untreated.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Chronic Obstructive Pulmonary Disease (COPD) diagnosed 5 years ago, hypertension, type 2 diabetes

• Current medications: Albuterol inhaler, Tiotropium, Lisinopril, Metformin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased shortness of breath and productive cough

• Key symptoms: Wheezing, fatigue, increased sputum production, mild fever

• Vital signs: Temperature 100.4°F, heart rate 98 bpm, respiratory rate 26 breaths per minute, blood pressure 145/85 mmHg, oxygen saturation 89% on room air

Section 1

In the early hours after admission, the patient's respiratory status continues to decline. His breathing becomes more labored, and he appears increasingly anxious. On reassessment, his oxygen saturation has dropped further to 85% on room air, and he is now tachypneic with a respiratory rate of 30 breaths per minute. Auscultation reveals diminished breath sounds in the lower lobes, coupled with coarse crackles and wheezing throughout the lung fields. The productive cough persists, with the sputum now appearing more purulent, suggesting a possible bacterial infection contributing to the exacerbation.

Laboratory results corroborate the clinical deterioration. The arterial blood gas analysis shows a pH of 7.32, PaCO2 of 58 mmHg, and PaO2 of 55 mmHg, indicating acute respiratory acidosis due to hypoventilation. Complete blood count reveals leukocytosis with a white blood cell count of 15,000/mm³, supporting the suspicion of an infectious process. Given these findings, the healthcare team must quickly address the hypoxemia and respiratory acidosis to prevent further deterioration, while considering the initiation of antibiotic therapy to target a likely underlying bacterial infection.

The team decides to initiate supplemental oxygen therapy to improve the patient's oxygen saturation, while also considering the use of non-invasive ventilation to support his respiratory effort and correct the acidosis. This approach aims to stabilize the patient and mitigate the risk of respiratory failure. The nursing staff closely monitors the patient's response to these interventions, ready to escalate care if required. As the situation evolves, a key focus will be on balancing oxygen therapy to avoid worsening hypercapnia, a common risk in COPD management.

Section 2

As the patient receives supplemental oxygen therapy via nasal cannula at 2 liters per minute, his oxygen saturation improves slightly to 88%, but his respiratory effort remains labored. The healthcare team decides to escalate to bilevel positive airway pressure (BiPAP) therapy to provide better support for ventilation and to help correct the respiratory acidosis. Within an hour of initiating BiPAP, the patient's respiratory rate decreases to 24 breaths per minute, and his oxygen saturation rises to 92%. However, he remains tachycardic with a heart rate of 110 beats per minute, and his anxiety persists, perhaps exacerbated by the unfamiliarity and discomfort of the BiPAP mask.

In conjunction with this respiratory support, the medical team initiates empirical antibiotic therapy with broad-spectrum coverage to address the suspected bacterial infection, while awaiting sputum culture results for targeted treatment. Despite these interventions, the patient's blood pressure begins to trend downwards, now reading at 95/60 mmHg, which raises concerns about potential sepsis or the effects of medications. The nursing team recognizes the need for vigilant monitoring for signs of shock or further hemodynamic instability.

As the situation evolves, the patient begins to complain of increasing chest discomfort. A repeat electrocardiogram (ECG) is ordered, revealing non-specific T-wave changes, which prompts consideration of a cardiac component in his clinical picture. Cardiac biomarkers are drawn to assess for possible myocardial ischemia or strain, given the increased workload on the heart due to persistent hypoxemia and respiratory distress. The team is now faced with the challenge of managing a complex interplay of respiratory and potential cardiac complications, requiring careful prioritization of interventions and continuous reassessment of the patient's condition.

Section 3

As the team awaits the results of the cardiac biomarkers, the patient's condition takes a turn. His chest discomfort intensifies, prompting a focused cardiovascular assessment. Upon examination, the nurse notes that the patient is diaphoretic and appears increasingly fatigued. His heart rate remains elevated at 110 beats per minute, and his blood pressure has further declined to 88/58 mmHg, raising the suspicion of cardiogenic involvement or worsening sepsis. The nursing team also observes that his skin is cool and clammy, and his capillary refill is delayed, indicating possible poor perfusion.

The laboratory results return, revealing elevated troponin levels, suggesting myocardial injury. This development necessitates a reevaluation of the current management strategy, as the potential overlap of cardiac and respiratory conditions could complicate the patient's clinical course. With the possibility of acute coronary syndrome on the differential, the medical team considers the addition of antiplatelet therapy and consults cardiology for further guidance. The patient's oxygen requirements remain high, and balancing his respiratory support with the need to prevent fluid overload becomes critical in managing his condition.

In response to these findings, the healthcare team intensifies their monitoring efforts. Continuous telemetry is initiated to better capture any arrhythmias or further cardiac changes. A decision is made to cautiously administer intravenous fluids to support his blood pressure, alongside vasopressor therapy if necessary, while ensuring that his respiratory status is not compromised. The clinical situation demands a coordinated approach, emphasizing the importance of integrating respiratory and cardiac care to stabilize the patient and prevent further deterioration.

Section 4

As the team initiates continuous telemetry and begins cautious intravenous fluid administration, they remain vigilant for any signs of hemodynamic instability or respiratory compromise. However, within a few hours, the patient's condition exhibits a new complication. He develops increasing respiratory distress, with a respiratory rate climbing to 32 breaths per minute and use of accessory muscles evident. Auscultation reveals diminished breath sounds in the lower lung fields, accompanied by diffuse crackles, suggesting the development of pulmonary edema. Despite supplemental oxygen via a high-flow nasal cannula, his oxygen saturation drops to 88%, indicating a mismatch in ventilation and perfusion.

Lab results corroborate the clinical findings, with a noted increase in brain natriuretic peptide (BNP) levels, reinforcing the suspicion of heart failure exacerbating the respiratory condition. A chest X-ray confirms bilateral infiltrates, consistent with pulmonary congestion. The medical team recognizes the delicate balance required and adjusts the treatment plan accordingly. Diuretics are cautiously introduced to relieve the pulmonary congestion while closely monitoring the patient's renal function and electrolyte status.

The response to interventions over the next few hours is mixed. While the diuretics help alleviate some of the pulmonary congestion, the patient's blood pressure remains borderline, necessitating careful titration of the vasopressor support. The nursing team meticulously monitors urine output and reassesses lung sounds frequently, alert for shifts in status. This period of intensive observation and management underscores the complexity of overlapping cardiac and pulmonary issues, demanding an adaptable approach in the ongoing stabilization of the patient. The next phase of care will focus on fine-tuning the balance between cardiac support and respiratory management, with a heightened awareness of potential further complications.

Section 5

As the medical team continues to navigate the patient's complex clinical picture, a new development arises that demands immediate attention. Despite initial stabilization efforts, the patient begins to exhibit signs of acute kidney injury (AKI), likely secondary to the aggressive diuretic therapy and borderline blood pressure. This is evidenced by a rising creatinine level, now at 2.1 mg/dL from a baseline of 1.0 mg/dL, and a decrease in urine output to less than 0.5 mL/kg/hr. The patient's electrolyte levels also show significant changes, with hypokalemia becoming apparent as the potassium level drops to 3.2 mEq/L.

The nursing team acts swiftly, adjusting the diuretic regimen while ensuring adequate renal perfusion is maintained. They initiate a careful balance of fluid administration to manage the patient's hemodynamic status without exacerbating the pulmonary edema. Concurrently, electrolyte replacement is started, with close monitoring of potassium levels to prevent cardiac arrhythmias. The patient's blood pressure remains tenuous, with systolic readings hovering around 90 mmHg, prompting a reevaluation of vasopressor support to optimize organ perfusion.

This new complication of AKI introduces an additional layer of complexity to the patient's care, requiring the team to integrate renal support into their management strategy. As they work to stabilize the patient, the focus shifts to ongoing assessment and careful titration of interventions. The multidisciplinary team collaborates closely, ensuring that each decision considers the interdependent cardiac, pulmonary, and renal systems. This phase underscores the importance of dynamic clinical reasoning as the team anticipates and mitigates further complications, preparing for potential adjustments in the patient's treatment plan.